HC Wainwright Brokers Lower Earnings Estimates for CVE:HIV

HIVE Blockchain Technologies Ltd. (CVE:HIV – Free Report) – Analysts at HC Wainwright decreased their Q3 2027 earnings per share (EPS) estimates for shares of HIVE Blockchain Technologies in a research report issued on Wednesday, November 11th. HC Wainwright analyst M. Colonnese now forecasts that the company will earn ($0.21) per share for the quarter, down from their prior estimate of ($0.13). HC Wainwright also issued estimates for HIVE Blockchain Technologies’ Q4 2027 earnings at ($0.16) EPS, Q1 2028 earnings at ($0.13) EPS, Q2 2028 earnings at ($0.11) EPS, Q3 2028 earnings at ($0.10) EPS, Q4 2028 earnings at ($0.11) EPS and FY2028 earnings at ($0.47) EPS.

Separately, Chardan Capital upgraded HIVE Blockchain Technologies to a “strong-buy” rating in a research report on Monday, July 27th. Two analysts have rated the stock with a Strong Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, HIVE Blockchain Technologies has a consensus rating of “Buy”.

Get Our Latest Report on HIVE Blockchain Technologies

HIVE Blockchain Technologies Price Performance

HIVE Blockchain Technologies Ltd. is a technology company in the Application Software industry.

Featured Articles

Earnings History and Estimates for HIVE Blockchain Technologies (CVE:HIV)

Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.